Metacrine, Inc. Common Stock
MTCR
MTCR was delisted on the 8th of February, 2023.
42 hedge funds and large institutions have $47.3M invested in Metacrine, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 47 → 42 (-5)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
42% less capital invested
Capital invested by funds: $82.1M → $47.3M (-$34.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
+$2.33M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$665K |
| 3 |
Renaissance Technologies
New York
|
+$330K |
| 4 |
Two Sigma Investments
New York
|
+$268K |
| 5 |
AC
Apogem Capital
New York
|
+$181K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$4.22M |
| 2 |
JP Morgan Chase
New York
|
-$1.29M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.11M |
| 4 |
BlackRock
New York
|
-$886K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$386K |
MTCR Hedge Fund Activity: Q2 2021 in Review
42 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q2 2021, worth a combined $47.3M — down 42% from $82.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of MTCR and 8 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 9 added.
The largest buyer was Prosight Management, adding an estimated $2.33M. The largest seller was VR Adviser, exiting entirely with an estimated $4.22M sold.
- 42 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q2 2021, down from 47 in Q1 2021.
- Funds reported $47.3M of Metacrine, Inc. Common Stock stock for Q2 2021, down 42% quarter-over-quarter.
- 8 funds opened new Metacrine, Inc. Common Stock positions in Q2 2021 and 13 closed out, a net change of -5 holders.
- The largest Metacrine, Inc. Common Stock buyer in Q2 2021 was Prosight Management, an estimated $2.33M added.
- The largest Metacrine, Inc. Common Stock seller in Q2 2021 was VR Adviser, an estimated $4.22M sold.
Based on aggregated 13F filings for Q2 2021.